daunorubicin liposomal

Skip to the navigation

Pronunciation: DAW noe ROO bi sin LYE poe SOE mal

Brand: Daunoxome

What is the most important information I should know about daunorubicin liposomal?

Daunorubicin liposomal may cause dangerous effects on your heart. Call your doctor at once if you have chest pain, shortness of breath (even with mild exertion), swelling, or rapid weight gain.

Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, nauseated, light-headed, sweaty, or have back pain and chest tightness.

Daunorubicin liposomal can lower blood cells that help your body fight infections and help your blood to clot. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches).

What is daunorubicin liposomal?

Daunorubicin liposomal is a cancer (antineoplastic) medication. Daunorubicin liposomal interferes with the growth of cancer cells and slows their growth and spread in the body.

Daunorubicin liposomal is used to treat advanced HIV-associated Kaposi's sarcoma.

Daunorubicin liposomal may also be used for purposes other than those listed in this medication guide.

What should I discuss with my healthcare provider before using daunorubicin liposomal?

You should not use daunorubicin liposomal if you are allergic to it.

To make sure daunorubicin liposomal is safe for you, tell your doctor if you have:

  • heart disease;
  • kidney disease;
  • liver disease;
  • a weak immune system (caused by disease or using certain medicines); or
  • if you have ever been treated with doxorubicin, epirubicin, idarubicin, mitoxantrone, or non-liposomal daunorubicin (Cerubidine).

Do not use daunorubicin liposomal if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.

Daunorubicin liposomal may pass into breast milk and may harm a nursing baby. You should not breast-feed while using this medicine.

How is daunorubicin liposomal given?

Daunorubicin liposomal is injected into a vein through an IV. A healthcare provider will give you this injection.

Before you receive each dose of daunorubicin liposomal, your heart function may need to be checked with an electrocardiograph or ECG (sometimes called an EKG). Your kidney and liver function may also need to be checked.

Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when daunorubicin liposomal is injected.

Skin accidentally exposed to daunorubicin liposomal should be rinsed thoroughly with soap and warm water.

Daunorubicin liposomal can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your daunorubicin liposomal injection.

What happens if I overdose?

Since this medication is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while using daunorubicin liposomal?

Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.

Do not receive a "live" vaccine while using daunorubicin liposomal, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.

This medicine can pass into body fluids (urine, feces, vomit). For at least 48 hours after you receive a dose, avoid allowing your body fluids to come into contact with your hands or other surfaces. Caregivers should wear rubber gloves while cleaning up a patient's body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.

What are the possible side effects of daunorubicin liposomal?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, nauseated, light-headed, sweaty, or have back pain and chest tightness.

Call your doctor at once if you have:

  • chest pain, shortness of breath (even with mild exertion), swelling, rapid weight gain;
  • fever, chills, body aches, flu symptoms, sores in your mouth and throat;
  • easy bruising, unusual bleeding (nose, mouth, vagina, or rectum);
  • nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or
  • pain, burning, irritation, or skin changes where the injection was given.

Common side effects may include:

  • mild nausea, vomiting, diarrhea, stomach pain;
  • cough;
  • headache;
  • temporary hair loss, mild itching or rash; or
  • red colored urine for 1 or 2 days following a dose.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect daunorubicin liposomal?

Other drugs may interact with daunorubicin liposomal, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

Where can I get more information?

Your healthcare provider may have additional information about daunorubicin liposomal that you may read.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2017 Cerner Multum, Inc. Version: 5.04. Revision date: 9/29/2015.

Your use of the content provided in this service indicates that you have read, understood and agree to the End-User License Agreement, which can be accessed by clicking on this link.